UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

European journal of cancer (1990), 2019-04, Vol.111, p.12-20

2019

Volltextzugriff (PDF)

French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) version 3

Supportive care in cancer, 2012-12, Vol.20 (12), p.3297-3305

2012

Volltextzugriff (PDF)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578

2013

Volltextzugriff (PDF)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578

2013

Volltextzugriff (PDF)

901 Reporting adverse events (AEs) in cancer surgery randomized trial: A systemic analysis of published trials in oesogastric (OG) and gynecological (GY) cancer patients

European journal of cancer (1990), 2015-09, Vol.51, p.S140-S140

2015

Volltextzugriff (PDF)

2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma

European journal of cancer (1990), 2015-09, Vol.51, p.S430-S430

2015

Volltextzugriff (PDF)

LBA-04The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii141-ii141

2016

Volltextzugriff (PDF)

2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study

European journal of cancer (1990), 2015-09, Vol.51, p.S360-S360

2015

Volltextzugriff (PDF)

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

British journal of cancer, 2010-04, Vol.102 (8), p.1207-1212

2010

Volltextzugriff (PDF)

1306 POSTER Accuracy of Clinical Judgment of Progressive Disease in Phase II Trials

European journal of cancer (1990), 2011, Vol.47, p.S165-S165

2011

Volltextzugriff (PDF)

Prognostic factors for adult sarcomas of head and neck

International journal of oral and maxillofacial surgery, 2008-05, Vol.37 (5), p.428-432

2008

Volltextzugriff (PDF)

Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis

International journal of oral and maxillofacial surgery, 2008-02, Vol.37 (2), p.135-139

2008

Volltextzugriff (PDF)

Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial

Value in health, 2021-05, Vol.24 (5), p.676-682

2021

Volltextzugriff (PDF)

Vulnerability assessment of the elderly cancer patients: Concordance between screening tests and subjective physician evaluation

Journal of geriatric oncology, 2012-10, Vol.3, p.S73-S73

2012

Volltextzugriff (PDF)

Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: Phase III EPIC trial

Annals of oncology, 2017-09, Vol.28, p.v267-v267

2017

Volltextzugriff (PDF)

Circulating vascular endothelial growth factor (VEGF) as prognostic factor of progression-free survival in patients with advanced chordoma receiving sorafenib: An analysis from a phase II trial of the French Sarcoma Group (GSF/GETO)

Annals of oncology, 2016-10, Vol.27, p.vi486-vi486

2016

Volltextzugriff (PDF)

Update of the T-DIS randomized phase II trial: Trabectedin rechallenge versus continuation in patients (pts) with advanced soft tissue sarcoma (ASTS)

Annals of oncology, 2016-10, Vol.27, p.vi486-vi486

2016

Volltextzugriff (PDF)

Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study

BMC cancer, 2018-04, Vol.18 (1), p.372-372, Article 372

2018

Volltextzugriff (PDF)

LBA-04 The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Annals of oncology, 2016-06, Vol.27, p.ii141

2016

Volltextzugriff (PDF)

Rebecca: a Large Cohort Study of Regorafenib (Reg) in the Real-Life Setting in Patients (Pts) Previously Treated for Metastatic Colorectal Cancer (Mcrc)

Annals of oncology, 2014-09, Vol.25, p.iv205

2014

Volltextzugriff (PDF)

Benefit of Maintenance Therapy with Trabectedin (T) Beyond the 6 First Cycles: Results of a Prospective Randomized Phase Ii Trial Comparing Interruption Vs. Continuation of T in Patients (Pts) with Advanced Soft Tissue Sarcoma (Asts): an Update

Annals of oncology, 2014-09, Vol.25, p.iv495

2014

Volltextzugriff (PDF)

Choi Vs. Recist Assessment of Tumor Response in a Retrospective Analysis of Patients (Pts) Receiving Trabectedin (T) for Advanced Soft Tissue Sarcomas (Asts)

Annals of oncology, 2014-09, Vol.25, p.iv504

2014

Volltextzugriff (PDF)

Abstract P2-13-10: Prospective randomized and multicentric evaluation of cognition in menopausal breast cancer patients receiving adjuvant hormonotherapy: a phase III study (Preliminary results)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-13-10

2012

Volltextzugriff (PDF)

Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues

Breast cancer research and treatment, 2010-12, Vol.124 (3), p.745-753

2010

Volltextzugriff (PDF)

Adult sarcomas: Incidence and initial management before implantation of regional sarcoma committee in northern France

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e20522-e20522

2010

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(118)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(57)
Humans
(56)
Oncology
(50)
Female
(43)
Male
(43)
Middle Aged
(38)
Aged
(36)
Adult
(29)
Aged, 80 And Over
(22)
Cancer
(22)
Life Sciences
(17)
Treatment Outcome
(17)
Chemotherapy
(16)
Tumors
(15)
Biological And Medical Sciences
(14)
Hematology, Oncology And Palliative Medicine
(14)
Medical Sciences
(14)
Medicine
(14)
Medicine & Public Health
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) version 3

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

901 Reporting adverse events (AEs) in cancer surgery randomized trial: A systemic analysis of published trials in oesogastric (OG) and gynecological (GY) cancer patients

2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma

LBA-04The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

1306 POSTER Accuracy of Clinical Judgment of Progressive Disease in Phase II Trials

Prognostic factors for adult sarcomas of head and neck

Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis

Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial

Vulnerability assessment of the elderly cancer patients: Concordance between screening tests and subjective physician evaluation

Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: Phase III EPIC trial

Circulating vascular endothelial growth factor (VEGF) as prognostic factor of progression-free survival in patients with advanced chordoma receiving sorafenib: An analysis from a phase II trial of the French Sarcoma Group (GSF/GETO)

Update of the T-DIS randomized phase II trial: Trabectedin rechallenge versus continuation in patients (pts) with advanced soft tissue sarcoma (ASTS)

Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study

LBA-04 The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Rebecca: a Large Cohort Study of Regorafenib (Reg) in the Real-Life Setting in Patients (Pts) Previously Treated for Metastatic Colorectal Cancer (Mcrc)

Benefit of Maintenance Therapy with Trabectedin (T) Beyond the 6 First Cycles: Results of a Prospective Randomized Phase Ii Trial Comparing Interruption Vs. Continuation of T in Patients (Pts) with Advanced Soft Tissue Sarcoma (Asts): an Update

Choi Vs. Recist Assessment of Tumor Response in a Retrospective Analysis of Patients (Pts) Receiving Trabectedin (T) for Advanced Soft Tissue Sarcomas (Asts)

Abstract P2-13-10: Prospective randomized and multicentric evaluation of cognition in menopausal breast cancer patients receiving adjuvant hormonotherapy: a phase III study (Preliminary results)

Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues

Adult sarcomas: Incidence and initial management before implantation of regional sarcoma committee in northern France

Suchergebnisse filtern